BEIJING ENT (00392) has a current Price-to-Book (P/B) ratio of 0.41. Compared to its 3-year average P/B ratio of 0.40, the current P/B ratio is approximately 2.50% higher. Relative to its 5-year average P/B ratio of 0.38, the current P/B ratio is about 7.52% higher. BEIJING ENT (00392) has a Forward Free Cash Flow (FCF) yield of approximately -2.62%. Compared to its 3-year average FCF yield of -8.72%, the current FCF yield is approximately -69.96% lower. Relative to its 5-year average FCF yield of -7.65%, the current FCF yield is about -65.77% lower.

Performance Decomposition

AI Analysis

Market capitalization of 00392 increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of 00392 in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is 00392 currently overvalued or undervalued?

What is BEIJING ENT (00392) fair value?

00392's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of BEIJING ENT (00392) is between to according to relative valuation method.

How does 00392's valuation metrics compare to the industry average?

The average P/S ratio for 00392's competitors is 0.00, providing a benchmark for relative valuation. BEIJING ENT Corp (00392) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for BEIJING ENT (00392) as of Mar 04 2026?

As of Mar 04 2026, BEIJING ENT (00392) has a P/B ratio of 0.41. This indicates that the market values 00392 at 0.41 times its book value.

What is the current FCF Yield for BEIJING ENT (00392) as of Mar 04 2026?

As of Mar 04 2026, BEIJING ENT (00392) has a FCF Yield of -2.62%. This means that for every dollar of BEIJING ENT's market capitalization, the company generates -2.62 cents in free cash flow.

What is the current Forward P/E ratio for BEIJING ENT (00392) as of Mar 04 2026?

As of Mar 04 2026, BEIJING ENT (00392) has a Forward P/E ratio of 6.77. This means the market is willing to pay $6.77 for every dollar of BEIJING ENT's expected earnings over the next 12 months.

What is the current Forward P/S ratio for BEIJING ENT (00392) as of Mar 04 2026?

As of Mar 04 2026, BEIJING ENT (00392) has a Forward P/S ratio of 0.42. This means the market is valuing 00392 at $0.42 for every dollar of expected revenue over the next 12 months.

00392 Valuation